Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cavazzoni Begins Putting Her Mark On FDA Drug Center With New Principal Deputy Position

Jul 07 2021

• By Sarah Karlin-Smith

FDA entrance sign 2016

Related Content

As Aducanumab’s US FDA Review Progressed, Support Grew For Accelerated Approval

Jun 23 2021

Woodcock Era At CDER Ends: Cavazzoni Becomes Permanent Director Of US FDA’s Drug Center

Apr 12 2021

US FDA Searches For Consistency On Assessment Of Real-World Evidence

Jul 29 2019

Cures 2.0 Leaders Sees Biden ‘Advanced Research’ Project As Ticket To Bill’s Success

May 19 2021

Public-Private Consortium To Strengthen Essential Medicines Supply Under White House Initiative

Jun 09 2021

Woodcock: The US FDA Sets The Stage For Global Quality Dossiers

Jan 10 2020

FDA Taps NIH Veteran Corrigan-Curay To Lead Medical Policy Office

Oct 06 2016

Related Companies

Biogen, Inc.

Additional Topics

United States FDA Leadership Regulation BioPharmaceutical

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window